Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Products In Brief

This article was originally published in The Gray Sheet

Executive Summary

Medtronic’s Endurant II AAA stent graft, Quest’s thyroid cancer test services and new Covidien Endo GIA staplers are among devices making market debuts.

You may also be interested in...



Research Briefs: Reports On HeartMate II Thromboses, Endurant AAA Graft Durability,Corus CAD Test

Three major teaching hospitals are reporting an unexpected increase in thrombosis in patients implanted with HeartMate II left ventricular assist devices since March 2011. More research news.

New Products In Brief

WL Gore’s endovascular graft for aortic tears and J&J/LifeScan’s OneTouch Verio IQ blood glucose monitor are among new products on the market.

Neuronetics Overcomes Negative Panel Review To Earn Clearance For NeuroStar

FDA cleared Neuronetics' NeuroStar transcranial magnetic stimulation system for drug-resistant depression, despite a negative advisory panel review, based on a pivotal study subset analysis

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031296

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel